Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Roche Holding AG published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-5 of 5
» View burbankleader.com items only
    May 12, 2013 |Story| Los Angeles Times

  1. Bill would regulate 'biosimilar' drugs

    SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs.
    SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs. At stake is a...

    Tags: Pharmaceuticals, Amgen Inc., Chemical Industry, Exports, Health and Medical Professionals

    2. Feb 1, 2012 | Allentown Morning Call

  2. New help for basal cell skin cancer patients

    Health
    On Monday, the U.S. Food & Drug Administration approved a new drug to treat advanced basal cell carcinoma, the most common form of skin cancer. This is good news for the approximately 2.8 million Americans who will be diagnosed with a basal-cell...
    3. Nov 7, 2009 |Story| Los Angeles Times

  3. New study may deal final blow to acne drug Accutane

    Teenagers and young adults suffering from severe, scarring acne may ultimately lose the most effective treatment for the condition.
    Teenagers and young adults suffering from severe, scarring acne may ultimately lose the most effective treatment for the condition. -------------------- FOR THE RECORD: Accutane's side effects: An article in Saturday's Section A about the possibility of...

    Tags: High Cholesterol, Physical Conditions, Pharmaceuticals, Colon, Bart Stupak

    4. Jun 19, 2007 |Story| Chicago Tribune

  4. Manager seeks growth, income for Janus fund

    Tribune Media Services columnist
    Q. I'd like to know more about Janus Growth & Income Fund, which was recommended to me. A. Minyoung Sohn, the fund's portfolio manager since early 2004, seeks both capital appreciation and income. The $6.8 billion Janus Growth & Income Fund (JAGIX),...

    Tags: CVS Corp., EMC Corporation, Money and Monetary Policy, Derivative Securities, Bank of New York Company

    5. Oct 19, 2005 |Story| Chicago Tribune

  5. U.S. lags on bird flu vaccine

    Tribune staff reporter
    Should a deadly bird flu spread quickly around the world, Americans could find themselves at the back of the line for any new vaccine developed to combat it. There are few U.S. vaccine makers. And even those, such as Deerfield-based Baxter...

    Tags: Pharmaceuticals, Sanofi-Aventis, Health and Safety at School, Death, Viral Diseases and Infections

Original site for Roche Holding AG topic gallery.
Advertisement